Evidence map›Paper›PMID 35445439›Full record

ArticleThe European journal of neuroscience2022

5-HT

Jacob R Thorstensen, Janet L Taylor, Justin J Kavanagh

Open access · hybridAbstract readControlled Clinical Trial
In one paragraph

Article in The European journal of neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. 5-HTThe Journal of physiology · 2025
    Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. 5-HTThe European journal of neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jacob R ThorstensenMenzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0002-6821-1547
Janet L TaylorSchool of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.ORCID 0000-0001-8976-5162
Justin J KavanaghMenzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0002-1046-260X
Griffith University · AUEdith Cowan University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intrinsic electrical properties of motoneurons strongly affect motoneuron excitability to fast-acting excitatory ionotropic inputs. Serotonin (5-HT) is a neurochemical that alters the intrinsic properties of motoneurons, whereby animal models and in vitro experiments indicate that 5-HT increases motoneuron excitability by activating 5-HT

Indexed as

Motor NeuronsSerotoninAxonsCyproheptadineDouble-Blind MethodElectric StimulationEvoked Potentials, MotorHumansMuscle, SkeletalSerotonin AntagonistsCyproheptadineSerotoninSerotonin Antagonistscervicomedullary motor evoked potentialF-waveionotropicneuromodulationraphe nucleiserotonin

Identifiers

PMID35445439
PMCPMC9543143
OpenAlexW4224232671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.